featured
Widely Metastatic ccRCC in 40-Year-Old Female
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
rebaz haji
use temsirolimus because poor risk category
Huan Wang
Considering type of histology is ccRCC. So I believe sunitinib or pazopanib is first-line treatment choice for the patient.